AP660A - A method of treatment of parasitic infection using IgE antagonists. - Google Patents
A method of treatment of parasitic infection using IgE antagonists. Download PDFInfo
- Publication number
- AP660A AP660A APAP/P/1996/000875A AP9600875A AP660A AP 660 A AP660 A AP 660A AP 9600875 A AP9600875 A AP 9600875A AP 660 A AP660 A AP 660A
- Authority
- AP
- ARIPO
- Prior art keywords
- ige
- antibody
- antagonist
- receptor
- parasite
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18408394A | 1994-01-18 | 1994-01-18 | |
| PCT/US1995/000087 WO1995019181A1 (en) | 1994-01-18 | 1995-01-05 | A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9600875A0 AP9600875A0 (en) | 1997-01-31 |
| AP660A true AP660A (en) | 1998-08-18 |
Family
ID=22675480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1996/000875A AP660A (en) | 1994-01-18 | 1995-01-05 | A method of treatment of parasitic infection using IgE antagonists. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5656273A (de) |
| EP (1) | EP0739214B1 (de) |
| JP (1) | JP3825798B2 (de) |
| AP (1) | AP660A (de) |
| AT (1) | ATE164079T1 (de) |
| DE (1) | DE69501817T2 (de) |
| DK (1) | DK0739214T3 (de) |
| MX (1) | MX9602818A (de) |
| PH (1) | PH31447A (de) |
| WO (1) | WO1995019181A1 (de) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL137649A (en) * | 1998-02-18 | 2004-08-31 | Genentech Inc | Method of adsorption chromatography |
| WO2000015260A1 (en) * | 1998-09-16 | 2000-03-23 | Tanox, Inc. | Anti-ige gene therapy |
| JP2003524602A (ja) * | 1998-09-18 | 2003-08-19 | ダイナバックス テクノロジーズ コーポレイション | IgE関連疾患の治療方法と、その治療において使用する組成物 |
| WO2002092125A1 (en) * | 2001-05-11 | 2002-11-21 | Novartis Ag | Compositions for use in treating ige-associated disorders |
| WO2002094228A1 (en) * | 2001-05-23 | 2002-11-28 | David Follansbee | Prevention and treatment of allergies by helminthic regulation of ige |
| EP1472275B1 (de) | 2002-02-05 | 2008-12-17 | Genentech, Inc. | Proteinaufreinigung |
| SI1501369T1 (sl) | 2002-04-26 | 2015-10-30 | Genentech, Inc. | Neafinitetno čiščenje proteinov |
| US20100003253A1 (en) * | 2002-11-08 | 2010-01-07 | Ablynx N.V. | Single domain antibodies directed against epidermal growth factor receptor and uses therefor |
| NZ540194A (en) * | 2002-11-08 | 2008-07-31 | Ablynx Nv | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| US20060034845A1 (en) * | 2002-11-08 | 2006-02-16 | Karen Silence | Single domain antibodies directed against tumor necrosis factor alpha and uses therefor |
| US9320792B2 (en) | 2002-11-08 | 2016-04-26 | Ablynx N.V. | Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
| JP4599355B2 (ja) | 2003-07-28 | 2010-12-15 | ジェネンテック, インコーポレイテッド | プロテインaアフィニティークロマトグラフィーの間のプロテインaの浸出の低減 |
| US20050065136A1 (en) * | 2003-08-13 | 2005-03-24 | Roby Russell R. | Methods and compositions for the treatment of infertility using dilute hormone solutions |
| WO2005105106A2 (en) * | 2004-04-21 | 2005-11-10 | Roby Russell R | Hormone treatment of macular degeneration |
| US20060025390A1 (en) * | 2004-07-28 | 2006-02-02 | Roby Russell R | Treatment of hormone allergy and related symptoms and disorders |
| US7662926B2 (en) | 2004-09-02 | 2010-02-16 | Genentech, Inc. | Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor |
| US7655229B2 (en) | 2004-09-02 | 2010-02-02 | Chan Andrew C | Anti-FC-gamma RIIB receptor antibody and uses therefor |
| JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
| JP2007172129A (ja) * | 2005-12-20 | 2007-07-05 | Sony Corp | 不揮発性メモリアクセス制御装置および不揮発性メモリ制御システム |
| FR2902799B1 (fr) | 2006-06-27 | 2012-10-26 | Millipore Corp | Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide |
| US20110104159A1 (en) * | 2006-09-11 | 2011-05-05 | Rohrs Brian R | Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| US20110105559A1 (en) * | 2006-09-11 | 2011-05-05 | Rohrs Brian R | Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy |
| PT2061444E (pt) * | 2006-09-11 | 2011-07-08 | Bausch & Lomb | Composições e métodos de tratamento, controlo, redução, melhoramento ou prevenção de alergias |
| US8163886B2 (en) | 2006-12-21 | 2012-04-24 | Emd Millipore Corporation | Purification of proteins |
| US8362217B2 (en) | 2006-12-21 | 2013-01-29 | Emd Millipore Corporation | Purification of proteins |
| US8569464B2 (en) | 2006-12-21 | 2013-10-29 | Emd Millipore Corporation | Purification of proteins |
| RU2474585C2 (ru) | 2007-01-22 | 2013-02-10 | Дженентек, Инк. | Осаждение и очистка белков полиэлектролитами |
| EP2586788B1 (de) | 2007-07-09 | 2017-11-29 | Genentech, Inc. | Verhindern der Disulfid-Bindungsreduktion während der rekombinanten Herstellung von Polypeptiden |
| HUE024877T2 (en) | 2007-10-30 | 2016-02-29 | Genentech Inc | Antibody purification by cation exchange chromatography |
| WO2009151514A1 (en) | 2008-06-11 | 2009-12-17 | Millipore Corporation | Stirred tank bioreactor |
| HUE066562T2 (hu) | 2008-08-14 | 2024-08-28 | Genentech Inc | Eljárások szennyezés eltávolítására indigén fehérje kiszorításos ioncserés membrán kromatográfia alkalmazásával |
| EP2684570A1 (de) | 2008-09-10 | 2014-01-15 | F. Hoffmann-La Roche AG | Zusammensetzungen und Verfahren zur Prävention des oxidativen Abbaus von Proteinen |
| DK2370561T3 (da) | 2008-12-16 | 2019-10-21 | Emd Millipore Corp | Omrøringstankreaktor og fremgangsmåde |
| US20110020327A1 (en) | 2008-12-16 | 2011-01-27 | Millipore Corporation | Purification of proteins |
| US8435488B2 (en) | 2009-02-27 | 2013-05-07 | Genentech, Inc. | Methods and compositions for protein labelling |
| MX355650B (es) | 2009-08-11 | 2018-04-26 | Genentech Inc | Produccion de proteinas en medios de cultivo de celulas libres de glutamina. |
| BR112012004697B8 (pt) | 2009-09-01 | 2021-05-25 | Genentech Inc | método para purificar um polipeptídeo compreendendo uma região ch2/ch3 |
| KR101878369B1 (ko) | 2010-03-22 | 2018-07-16 | 제넨테크, 인크. | 단백질-함유 제제의 안정화에 유용한 조성물 및 방법 |
| BR112012027828A2 (pt) | 2010-05-03 | 2016-08-09 | Genentech Inc | composição de matéria, artigo de fabricação e método de redução da viscosidade de uma formulação contendo proteína e de preparação de uma formulação aquosa contendo proteína |
| CN102892791B (zh) | 2010-05-17 | 2017-05-17 | Emd密理博公司 | 用于纯化生物分子的刺激响应性聚合物 |
| JP6050226B2 (ja) | 2010-05-28 | 2016-12-21 | ジェネンテック, インコーポレイテッド | Ldh及びpdhk発現を下方制御することによる乳酸レベルの低下及びポリペプチド生産の増加 |
| KR101924653B1 (ko) | 2010-06-24 | 2018-12-03 | 제넨테크, 인크. | 단백질-함유 제제를 안정화시키기 위한 알킬글리코시드 함유 조성물 및 방법 |
| CN104474546A (zh) | 2010-08-13 | 2015-04-01 | 弗·哈夫曼-拉罗切有限公司 | 用于疾病治疗的针对IL-1β和IL-18的抗体 |
| WO2012030512A1 (en) | 2010-09-03 | 2012-03-08 | Percivia Llc. | Flow-through protein purification process |
| WO2013009491A2 (en) | 2011-07-08 | 2013-01-17 | Nripen Singh | Improved depth filters for disposable biotechnological processes |
| PL2794635T3 (pl) | 2011-12-22 | 2019-02-28 | F.Hoffmann-La Roche Ag | Membranowa chromatografia jonowymienna |
| SG11201406112TA (en) | 2012-03-27 | 2014-10-30 | Genentech Inc | Improved harvest operations for recombinant proteins |
| SI2849723T1 (sl) | 2012-05-18 | 2018-09-28 | Genentech, Inc. | Formulacije z visoko koncentracijo monoklonskih protiteles |
| WO2014100095A1 (en) | 2012-12-19 | 2014-06-26 | Genentech, Inc. | Methods and compositions for radiohalogen protein labeling |
| CN106686977B (zh) | 2014-07-09 | 2022-03-25 | 豪夫迈·罗氏有限公司 | Ph调整以改善细胞库的解冻复苏 |
| JP2019510517A (ja) | 2016-03-29 | 2019-04-18 | ジェルター, インコーポレイテッド | 細胞質内体積に対するペリプラズム体積の比率が0.5:1および10:1の間にあるグラム陰性細菌におけるタンパク質の発現 |
| AU2017382281B2 (en) | 2016-12-22 | 2024-07-11 | Genentech, Inc. | Methods and formulations for reducing reconstitution time of lyophilized polypeptides |
| US11180541B2 (en) | 2017-09-28 | 2021-11-23 | Geltor, Inc. | Recombinant collagen and elastin molecules and uses thereof |
| IL279782B2 (en) | 2018-07-03 | 2026-05-01 | Bristol Myers Squibb Co | Methods for producing recombinant proteins |
| KR20210074341A (ko) | 2018-10-10 | 2021-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 고밀도 생물 반응기 배양에서 막 기체 전달을 위한 방법 |
| WO2020205716A1 (en) | 2019-04-01 | 2020-10-08 | Genentech, Inc. | Compositions and methods for stabilizing protein-containing formulations |
| GB2597416A (en) | 2019-04-12 | 2022-01-26 | Geltor Inc | Recombinant elastin and production thereof |
| US20220315887A1 (en) | 2019-08-01 | 2022-10-06 | Bristol-Myers Squibb Company | Methods of improving protein productivity in fed-batch cell cultures |
| CN116194570A (zh) | 2020-09-22 | 2023-05-30 | 百时美施贵宝公司 | 用于产生治疗性蛋白的方法 |
| US20250115666A1 (en) | 2021-08-05 | 2025-04-10 | Bristol-Myers Squibb Company | Cell culture methods for producing therapeutic proteins |
| US20240390869A1 (en) | 2021-09-21 | 2024-11-28 | Bristol-Myers Squibb Company | Methods of controlling the level of dissolved oxygen (do) in a solution comprising a recombinant protein in a storage container |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0476226A1 (de) * | 1990-09-18 | 1992-03-25 | Shionogi Seiyaku Kabushiki Kaisha | Monoklonale Antikörper gegen menschliches IgE |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946788A (en) * | 1985-06-11 | 1990-08-07 | Ciba-Geigy Corporation | Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications |
| US4714759A (en) * | 1985-12-02 | 1987-12-22 | Whitaker Jr Robert B | Immunotoxin therapy of allergy |
| US4940782A (en) * | 1987-06-08 | 1990-07-10 | G. D. Searle & Co. | Monoclonal antibodies against IgE-associated determinants, hybrid cell lines producing these antibodies, and use therefore |
| US4962035A (en) * | 1987-12-01 | 1990-10-09 | President And Fellows Of Harvard College | DNA encoding IgE receptor alpha-subunit or fragment thereof |
| US5252467A (en) * | 1987-12-31 | 1993-10-12 | Tanox Biosystems, Inc. | Method of making antibodies to antigenic epitopes of IGE present on B cells but not basophil cell surface or secreted, soluble IGE |
| US5091313A (en) * | 1988-08-05 | 1992-02-25 | Tanox Biosystems, Inc. | Antigenic epitopes of IgE present on B cell but not basophil surface |
| EP0617127A1 (de) * | 1987-12-31 | 1994-09-28 | Tanox Biosystems, Inc. | Antigene Epitope auf B-Zell-gebundene IgE Immunglobulinen |
| EP1260521B1 (de) * | 1991-08-14 | 2007-11-21 | Genentech Inc. | Immunglobulinvarianten für spezifische Fc-epsilon Rezeptoren |
| SE9102808L (sv) * | 1991-09-26 | 1993-03-27 | Lars T Hellman Inst F Immunolo | Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner |
-
1995
- 1995-01-05 AP APAP/P/1996/000875A patent/AP660A/en active
- 1995-01-05 DE DE69501817T patent/DE69501817T2/de not_active Expired - Fee Related
- 1995-01-05 DK DK95907302T patent/DK0739214T3/da active
- 1995-01-05 MX MX9602818A patent/MX9602818A/es unknown
- 1995-01-05 EP EP95907302A patent/EP0739214B1/de not_active Expired - Lifetime
- 1995-01-05 JP JP51821495A patent/JP3825798B2/ja not_active Expired - Lifetime
- 1995-01-05 WO PCT/US1995/000087 patent/WO1995019181A1/en not_active Ceased
- 1995-01-05 AT AT95907302T patent/ATE164079T1/de not_active IP Right Cessation
- 1995-01-09 PH PH49755A patent/PH31447A/en unknown
- 1995-04-14 US US08/422,748 patent/US5656273A/en not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0476226A1 (de) * | 1990-09-18 | 1992-03-25 | Shionogi Seiyaku Kabushiki Kaisha | Monoklonale Antikörper gegen menschliches IgE |
Non-Patent Citations (1)
| Title |
|---|
| THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 92,no. 3, September 1993 ST.LOUIS, MO, USA, pages 404-411 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3825798B2 (ja) | 2006-09-27 |
| MX9602818A (es) | 1997-06-28 |
| PH31447A (en) | 1998-11-03 |
| ATE164079T1 (de) | 1998-04-15 |
| DE69501817D1 (de) | 1998-04-23 |
| AP9600875A0 (en) | 1997-01-31 |
| US5656273A (en) | 1997-08-12 |
| WO1995019181A1 (en) | 1995-07-20 |
| EP0739214A1 (de) | 1996-10-30 |
| JPH10503749A (ja) | 1998-04-07 |
| DE69501817T2 (de) | 1998-09-10 |
| DK0739214T3 (da) | 1998-10-07 |
| EP0739214B1 (de) | 1998-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5656273A (en) | Method of treatment of parasitic infection using IgE antagonists | |
| EP0841946B1 (de) | Verfahren zur behandlung von allergischem asthma | |
| US6660266B1 (en) | Reversal of proinflammatory response by ligating the macrophage FcγRI receptor | |
| KR100493980B1 (ko) | 면역학적질병의치료를위한치료제로서가용성림포톡신-베타수용체및항-림포톡신수용체및리간드항체 | |
| MXPA98000760A (en) | Methods for the treatment of asthma allergy | |
| US20110311520A1 (en) | Methods for treatment of allergic asthma | |
| JPH08505365A (ja) | 自己免疫疾患および炎症性疾患の治療 | |
| EP1159003B1 (de) | Antikörper gegen tnf alpha zur therapie von steroidresistentem asthma | |
| US20090010928A1 (en) | Anti-anthrax antibody, formulations thereof, and methods of use | |
| US9587034B2 (en) | Anti-mIgE antibodies that bind to the junction between CH4 and CεmX domains | |
| US20020076404A1 (en) | Treating atopic dermatitis with IgE antagonists | |
| WO1997010004A1 (en) | Methods for treatment of interstitial cystitis | |
| WO1999038531A1 (en) | TREATING ATOPIC DERMATITIS WITH IgE ANTAGONISTS | |
| US20020006402A1 (en) | Administering IgE antagonists during pregnancy to ameliorate allergic diseases in the offspring | |
| Salagean et al. | IgE and Anti-IgE Therapy in Allergic Asthma and Rhinitis | |
| WO1998046255A1 (en) | Inhibition of b-1 cell mediated immune conditions |